Lobbyist · LDA.gov number 144371

ILHAAM JAFFER

1 reportConfirmed from the official record

ILHAAM JAFFER is named as a lobbyist in 1 lobbying report we hold, filed by 1 registrant for 1 client.

Every lobbyist

Earlier government jobs, as reported

A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.

No report we hold lists a covered position for ILHAAM JAFFER.

Registrants and clients

Clients: ASSOCIATION FOR ACCESSIBLE MEDICINES.

Bills named where this lobbyist is listed, and how the House and the Senate voted

21 bills named in these reports. 1 of them became law, and our record holds how the House and the Senate voted on it. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.

Bills named in reports that list ILHAAM JAFFER
BillStatusHow the House and the Senate voted
H.R. 7148Consolidated Appropriations Act, 2026Became lawPublic Law 119-75House 217–214 · Senate 71–29
H.R. 1051To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.IntroducedNo recorded vote in our record
H.R. 3152Patent Eligibility Restoration Act of 2025IntroducedNo recorded vote in our record
H.R. 3160PREVAIL ActIntroducedNo recorded vote in our record
H.R. 3269ETHIC ActIntroducedNo recorded vote in our record
H.R. 5526Biosimilar Red Tape Elimination ActIntroducedNo recorded vote in our record
H.R. 5811Restoring America’s Leadership in Innovation Act of 2025IntroducedNo recorded vote in our record
H.R. 6485Skinny Labels, Big Savings ActIntroducedNo recorded vote in our record
H.R. 8269CLEAR LABELS ActIntroducedNo recorded vote in our record
H.R. 8339Drug Origin Transparency Act of 2026IntroducedNo recorded vote in our record
S. 43Skinny Labels, Big Savings ActIntroducedNo recorded vote in our record
S. 1041Affordable Prescriptions for Patients ActPassed the SenateNo recorded vote in our record
S. 1096Preserve Access to Affordable Generics and Biosimilars ActReported by committeeNo recorded vote in our record
S. 1414Expedited Access to Biosimilars ActReported by committeeNo recorded vote in our record
S. 1546Patent Eligibility Restoration Act of 2025IntroducedNo recorded vote in our record
S. 1553PREVAIL ActIntroducedNo recorded vote in our record
S. 1954Biosimilar Red Tape Elimination ActReported by committeeNo recorded vote in our record
S. 2276ETHIC ActIntroducedNo recorded vote in our record
S. 2658Medication Affordability and Patent Integrity ActReported by committeeNo recorded vote in our record
S. 3469BIOSECURE Act of 2025IntroducedNo recorded vote in our record
S. 3788CLEAR LABELS ActReported by committeeNo recorded vote in our record

Issues named: Copyright/Patent/Trademark (1), Medicare/Medicaid (1), Pharmacy (1), Trade (domestic/foreign) (1).

Every report

Lobbying reports that name ILHAAM JAFFER
ClientRegistrantKind, as filedPostedReport
ASSOCIATION FOR ACCESSIBLE MEDICINESPharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)ASSOCIATION FOR ACCESSIBLE MEDICINES2nd Quarter - ReportThe report on LDA.gov

Campaign gifts this lobbyist reported

Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.

No contribution report we hold lists a gift from this filer.

Where this comes from

Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .

2026-Q2: every page of LDA.gov's list saved and read.

A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.

Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.

Suggest a tool

Suggest a tool

A person reads each idea before it appears. Links are not accepted. Do not include personal information.

See all ideas and vote